Company Information

  

Address: 2500 CROSSPARK ROAD, SUITE E126  
City: CORALVILLE 
State: IA 
Zip Code: 52241 
Telephone: 319-665-2575 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

We are a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs that we believe will be improved versions of widely prescribed, approved drugs. We employ our Ligand Activated Therapy, or LAT, platform technology to create our prodrugs. We are building a pipeline of prodrug product candidates that target large market opportunities in pain, attention deficit hyperactivity disorder, or ADHD, and central nervous system, or CNS, disorders. Our two lead product candidates are KP415, our extended release, or ER, d-threo-methylphenidate product candidate for the treatment of ADHD, and KP201/IR, our acetaminophen, or APAP, free, single-entity, benzhydrocodone hydrochloride immediate-release, or IR, abuse-deterrent product candidate designed for the treatment of acute pain.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/2017-1.33NAN/E
03/2017-2.04NAN/E
12/2016-1.13NAN/E
09/2016-3.16NAN/E
06/2016-3.87NAN/E
03/2016-7.12NAN/E
12/2015-7.42NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity-0.16Total Liab/Total Assets1.22
Net Inc/Total Assets-0.19Total Liab/Inv Cap1.33
Net Inc/Inv Cap-0.21Total Liab/Comm Equity1.01
Pretax Inc/Net SalesNAInterest Coverage Ratio-1.32
Net Inc/Net SalesNACurr Debt/Equity-0.01
Cash Flow/Net SalesNALTD/Equity-5.12
SG&A/NetSalesNATotal Debt/Equity-5.13
Asset Utilization   Liquidity  
Net Receivables TurnoverNAQuick Ratio11.19
Inventory TurnoverNACurrent Ratio11.19
Inventory Day SalesNANet Rec/Curr Assets0.07
Net Sales/Work CapNAInv/Curr AssetsNA
Net Sales/PP&ENA  

Income Statement (Millions)

  6/30/2017 3/31/2017 12/31/2016 9/30/2016
Total Revenues(Net Sales) 0.00 0.00 0.00 0.00
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 3.57 3.27 2.87 6.11
Operating Income -8.22 -7.38 -10.84 -10.40
Interest Exp 1.83 1.83 1.84 1.83
Pretax Income -6.52 -16.33 -9.94 -13.43
Other Income 3.54 -7.12 2.73 -1.20
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -6.52 -16.32 -9.94 -13.41

Balance Sheet (Millions)

Assets 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Cash & Short Term Investments 54.59 62.22 68.87 64.63
Receivables - Total 0.00 0.00 5.00 NA
Inventories - Total NA NA NA NA
Total Current Assets 55.36 63.02 74.36 65.26
Net Property, Plant & Equipment 2.15 2.20 1.97 1.46
Total Assets 69.05 75.64 84.89 94.54
Liabilities        
Accounts Payable 6.30 4.58 6.44 5.60
Debt in Current Liabilities 0.18 0.16 0.16 0.11
Total Current Liabilities 6.59 4.81 6.64 5.70
Long-Term Debt 100.26 103.39 95.79 98.12
Total Liabilities 108.33 109.57 103.58 104.35
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.00 0.00 0.00 0.00
Retained Earnings -144.18 -137.66 -121.34 -111.40
Treasury Stock NA NA NA NA
Total Stockholders' Equity -39.28 -33.93 -18.70 -9.80
Total Liabilities and Stockholders' Equity 69.05 75.64 84.89 94.54

Cash Flow Summary (Millions)

Categories 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Net Cash Provided by Operating Activities -6.47 -9.52 -9.65 -7.98
Net Cash Provided by Investing Activities 6.04 5.70 5.74 2.52
Net Cash Provided by Financing Activities -0.06 -0.06 -0.17 -2.30

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20130.00-5.23--
12/20140.00-24.46--
12/20150.00-54.66-7.42
12/20160.00-16.52-1.13
Growth RatesNaN----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/17345,87340.07




Report Date : 10/16/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.